Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)
- Conditions
- B-cell Chronic Lymphocytic Leukemia
- Interventions
- Drug: FCCam
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 61
- Registration Number
- NCT00147901
- Locations
- π©πͺ
University of Cologne, Cologne, NRW, Germany
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2010-01-27
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 30
- Registration Number
- NCT00147953
- Locations
- π©πͺ
University of Cologne, Cologne, NRW, Germany
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
- Conditions
- Hodgkin Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2008-07-10
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 37
- Registration Number
- NCT00148018
- Locations
- π©πͺ
University of Cologne, Cologne, NRW, Germany
Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma
- Conditions
- Hodgkin's Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2009-09-07
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 60
- Registration Number
- NCT00147875
- Locations
- π©πͺ
University of Cologne, Cologne, NRW, Germany
The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.
- Conditions
- HIV Infections
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00145561
- Locations
- π³π±
Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands
π³π±Erasmus Medical Centre, Rotterdam, Netherlands
π³π±Rijnstate Hospital, Arnhem, Netherlands
Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Vion Pharmaceuticals
- Target Recruit Count
- 420
- Registration Number
- NCT00112554
- Locations
- πΊπΈ
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
πΊπΈDana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
πΊπΈRiverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
- Conditions
- Gastrointestinal Stromal Tumor
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 40
- Registration Number
- NCT00112632
- Locations
- π©πͺ
Southwest German Cancer Center at Eberhard-Karls-University, Tuebingen, Germany
π©πͺUniversitaetsklinikum Bonn, Bonn, Germany
π©πͺMedizinische Universitaetsklinik I at the University of Cologne, Cologne, Germany
Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
- Conditions
- Neuroblastoma
- First Posted Date
- 2004-05-12
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 44
- Registration Number
- NCT00002803
- Locations
- π©πͺ
University of Cologne, Frechen, Germany
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
- Conditions
- Neuroblastoma
- First Posted Date
- 2004-05-12
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 500
- Registration Number
- NCT00002802
- Locations
- π©πͺ
University of Cologne, Frechen, Germany
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged β₯ 60 Years
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Target Recruit Count
- 175
- Registration Number
- NCT00079105
- Locations
- π¬π§
Royal United Hospital, Bath, England, United Kingdom
π¬π§Kent and Canterbury Hospital, Canterbury, England, United Kingdom
π¬π§Saint Richards Hospital, Chichester, England, United Kingdom